Status:

COMPLETED

Impact of Intracoronary Versus Intravenous Epinephrine Administration During Cardiac Arrest .

Lead Sponsor:

Lithuanian University of Health Sciences

Collaborating Sponsors:

Baylor Scott and White Health

Minneapolis Heart Institute

Conditions:

Cardiopulmonary Arrest

Epinephrine Causing Adverse Effects in Therapeutic Use

Eligibility:

All Genders

18+ years

Brief Summary

In hospital cardiac arrest (IHCA) is a major challenge imposed on almost all health care systems worldwide. Despite significant progress in cardiopulmonary resuscitation in the past few years, outcome...

Eligibility Criteria

Inclusion

  • Aged above 18 years old
  • Diagnosed with non-ST elevation myocardial infarction (NSTEMI) or ST elevation myocardial infarction (STEMI)
  • Received dual antiplatelet therapy (acetylsalicylic acid and ticagrelor), or triple therapy (oral anticoagulant, acetylsalicylic acid and clopidogrel)
  • Event of cardiac arrest during percutaneous intervention

Exclusion

  • cardiac arrest documented prior to being transported to cardiac catheterization laboratory.
  • Patients who suffered cardiac arrest for less than 60 seconds were excluded from the study.
  • Received mechanical circulatory support such as intra-aortic balloon pump, temporary percutaneous ventricular assist devices, or extracorporeal membrane oxygenation (ECMO) during hospitalization.
  • Presenting with any cardiac rhythm on admission other than sinus rhythm or atrial fibrillation/flutter
  • Signs of infection or a history of hepatic, oncologic or allergy to contrast media and end stage renal failure
  • Patients who underwent primary fibrinolysis.
  • Furthermore, patients who received atropine, amiodarone, lidocaine, or any other antiarrhythmic prior to CPR
  • who received targeted temperature management post CPR .

Key Trial Info

Start Date :

April 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2022

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT05253937

Start Date

April 1 2018

End Date

June 1 2022

Last Update

August 16 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ali Aldujeli

Kaunas, Lithuania, LT-50161